Lataa...
Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease
Patients with chronic inflammatory diseases (CID) experience accelerated loss of bone mineral density, which is often accompanied by increased vascular calcification. These disturbances can be attenuated by therapies for inflammation, such as the tumor necrosis factor inhibitor infliximab. Calciprot...
Tallennettuna:
| Julkaisussa: | JBMR Plus |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216135/ https://ncbi.nlm.nih.gov/pubmed/34189386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10497 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|